State Street Corp Invests $1.98 Million in Ardent Health Partners, LLC (NYSE:ARDT)

State Street Corp bought a new stake in Ardent Health Partners, LLC (NYSE:ARDT) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 107,560 shares of the company’s stock, valued at approximately $1,977,000. State Street Corp owned 0.08% of Ardent Health Partners as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in ARDT. BNP Paribas Financial Markets purchased a new position in Ardent Health Partners during the third quarter valued at $42,000. Financial Management Professionals Inc. purchased a new position in Ardent Health Partners during the 3rd quarter valued at about $50,000. MetLife Investment Management LLC bought a new stake in Ardent Health Partners during the third quarter worth about $135,000. Quadrature Capital Ltd purchased a new stake in Ardent Health Partners in the third quarter worth about $229,000. Finally, Centiva Capital LP bought a new position in shares of Ardent Health Partners during the third quarter valued at approximately $469,000.

Analysts Set New Price Targets

ARDT has been the topic of a number of analyst reports. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their target price for the stock from $22.00 to $19.00 in a research note on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. Leerink Partners increased their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research report on Tuesday, November 12th. Finally, KeyCorp initiated coverage on shares of Ardent Health Partners in a report on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price for the company. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $22.00.

Ardent Health Partners Stock Performance

Shares of Ardent Health Partners stock opened at $17.08 on Thursday. Ardent Health Partners, LLC has a twelve month low of $14.57 and a twelve month high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The firm’s 50 day moving average is $16.79.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.